OBJECTIVE: Although the Malawian government recommends HIV-exposed infants receive early infant diagnosis (EID) of HIV at "under-five" pediatric clinics (U5Cs), most never enroll. Therefore, we evaluated the integration of EID testing into an immunization clinic (IC) compared with the current standard of EID testing at an U5C. DESIGN: Prospective observational study. METHODS: Using routine provider-initiated HIV testing and counseling (PITC) registers, we prospectively studied 1757 children offered PITC at a government IC and U5C. Infants tested by HIV DNA polymerase chain reaction (PCR) were followed until PCR result disclosure or defaulting. RESULTS: We sampled 877 and 880 consecutive PITC recipients at U5C and IC, respectively. Overall, a 7-fold greater proportion received PITC at IC (84.2% vs. 11.4%, P < 0.001). PITC recipients at IC were more than 14 months younger (2.6 vs. 17.0, P < 0.001), with greater proportions HIV exposed (17.6% vs. 5.3%, P < 0.001) and PCR eligible (7.9% vs. 3.5%, P < 0.001). A higher percentage of IC infants accepted PCR testing (100.0% vs. 90.3%, P = 0.03). Additionally, IC PCR recipients were 2.5 months younger (3.1 vs. 5.6, P < 0.001) with 4 times less testing PCR positive (7.1% vs. 32.1%, P < 0.001). Importantly, a more than 3-fold greater proportion of HIV-exposed infants at IC returned for their PCR result and enrolled into care (78.6% vs. 25.0%, P < 0.001). CONCLUSIONS: Compared with an U5C, integrating EID testing into an IC is more acceptable, more feasible, enrolls more infants into EID at younger ages, and would likely strengthen Malawi's EID services if expanded.
OBJECTIVE: Although the Malawian government recommends HIV-exposed infants receive early infant diagnosis (EID) of HIV at "under-five" pediatric clinics (U5Cs), most never enroll. Therefore, we evaluated the integration of EID testing into an immunization clinic (IC) compared with the current standard of EID testing at an U5C. DESIGN: Prospective observational study. METHODS: Using routine provider-initiated HIV testing and counseling (PITC) registers, we prospectively studied 1757 children offered PITC at a government IC and U5C. Infants tested by HIV DNA polymerase chain reaction (PCR) were followed until PCR result disclosure or defaulting. RESULTS: We sampled 877 and 880 consecutive PITC recipients at U5C and IC, respectively. Overall, a 7-fold greater proportion received PITC at IC (84.2% vs. 11.4%, P < 0.001). PITC recipients at IC were more than 14 months younger (2.6 vs. 17.0, P < 0.001), with greater proportions HIV exposed (17.6% vs. 5.3%, P < 0.001) and PCR eligible (7.9% vs. 3.5%, P < 0.001). A higher percentage of IC infants accepted PCR testing (100.0% vs. 90.3%, P = 0.03). Additionally, IC PCR recipients were 2.5 months younger (3.1 vs. 5.6, P < 0.001) with 4 times less testing PCR positive (7.1% vs. 32.1%, P < 0.001). Importantly, a more than 3-fold greater proportion of HIV-exposed infants at IC returned for their PCR result and enrolled into care (78.6% vs. 25.0%, P < 0.001). CONCLUSIONS: Compared with an U5C, integrating EID testing into an IC is more acceptable, more feasible, enrolls more infants into EID at younger ages, and would likely strengthen Malawi's EID services if expanded.
Authors: Monique van Lettow; Richard Bedell; Megan Landes; Lucy Gawa; Stephanie Gatto; Isabell Mayuni; Adrienne K Chan; Lyson Tenthani; Erik Schouten Journal: BMC Public Health Date: 2011-06-03 Impact factor: 3.295
Authors: Maureen Braun; Mark M Kabue; Eric D McCollum; Saeed Ahmed; Maria Kim; Leela Aertker; Marko Chirwa; Michael Eliya; Innocent Mofolo; Irving Hoffman; Peter N Kazembe; Charles van der Horst; Mark W Kline; Mina C Hosseinipour Journal: J Acquir Immune Defic Syndr Date: 2011-04-15 Impact factor: 3.731
Authors: Eric D McCollum; Geoffrey A Preidis; Mark M Kabue; Emmanuel B M Singogo; Charles Mwansambo; Peter N Kazembe; Mark W Kline Journal: PLoS One Date: 2010-03-10 Impact factor: 3.240
Authors: Avy Violari; Mark F Cotton; Diana M Gibb; Abdel G Babiker; Jan Steyn; Shabir A Madhi; Patrick Jean-Philippe; James A McIntyre Journal: N Engl J Med Date: 2008-11-20 Impact factor: 91.245
Authors: Muktar H Aliyu; Meridith Blevins; Karen M Megazzini; Carolyn M Audet; Julie Dunlap; Ibrahim S Sodangi; Usman I Gebi; Bryan E Shepherd; C William Wester; Sten H Vermund Journal: J Acquir Immune Defic Syndr Date: 2014-09-01 Impact factor: 3.731
Authors: Charles Kiyaga; Hakim Sendagire; Eleanor Joseph; Jeff Grosz; Ian McConnell; Vijay Narayan; Godfrey Esiru; Peter Elyanu; Zainab Akol; Wilford Kirungi; Joshua Musinguzi; Alex Opio Journal: J Public Health Policy Date: 2015-03-26 Impact factor: 2.222
Authors: Surbhi Modi; Tegan Callahan; Jessica Rodrigues; Mwikemo D Kajoka; Helen M Dale; Judite O Langa; Marilena Urso; Matsepeli I Nchephe; Helene Bongdene; Sostena Romano; Laura N Broyles Journal: J Acquir Immune Defic Syndr Date: 2017-05-01 Impact factor: 3.731
Authors: Nandita Sugandhi; Jessica Rodrigues; Maria Kim; Saeed Ahmed; Anouk Amzel; Mike Tolle; Eric J Dziuban; Scott E Kellerman; Emilia Rivadeneira Journal: AIDS Date: 2013-11 Impact factor: 4.177
Authors: Saeed Ahmed; Maria H Kim; Nandita Sugandhi; B Ryan Phelps; Rachael Sabelli; Mamadou O Diallo; Paul Young; Dana Duncan; Scott E Kellerman Journal: AIDS Date: 2013-11 Impact factor: 4.177
Authors: Geoffrey A Preidis; Eric D McCollum; William Kamiyango; Alejandro Garbino; Mina C Hosseinipour; Peter N Kazembe; Gordon E Schutze; Mark W Kline Journal: J Acquir Immune Defic Syndr Date: 2013-05-01 Impact factor: 3.731